Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant protein vaccine

· ImmunoFrontier, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant protein vaccine, covering 2013-04-17 to 2013-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of a Recombinant Protein Vaccine to Treat Esophageal Cancer [Phase 1]

See pricing